Jasmine Kamboj, Physician at Mayo Clinic Health System, Podcast Editor and Host of the ‘Empowering Oncologists’ podcast at OncoDaily, shared on X:
’’I am truly honored to have come across the two podcasts highlighting similarities in challenges across the borders.
Shushan Hovsepyan and Lisa Thompson Smith discuss issues around -drug access to community settings in the United States
- how providing care closer to home is a ‘calling’ and may be leading to better cancer outcomes, as presented at Community Oncology Alliance 2026
- how reimbursement has lagged behind by 33 percent for community clinics that puts financial strains on them and further create barriers to allow care in a timely fashion when drugs are approved
- how ‘behind the scene’ process of have evolved and gotten more complex over time in terms of drug access.
We may the getting onto the AI era where we may find some solutions to these challenges!
The second one is by Dr Sumanta Pal, Atul Batra highlighting similar ‘access’ and drug delivery challenges in LMICs. The ‘lag period’ between FDA approval and availability of drugs. How do we apply research and newer treatments if we have access issues?
As a community oncologist who practices in a single physician run clinic, and is going through the arduous process to get Daraxonrasib for the single advanced pancreatic patient, and as a passionate global oncologist who feels deeply to do better for our patients globally, I can empathize and echo with every word mentioned in the above podcasts.
Thanks ASCO, Dr Eric Small, OncoDaily and Gevorg Tamamyan for putting light on such issues. I agree, we are all more similar than different. We need to have better access locally and globally.”
Other articles featuring Jasmine Kamboj on OncoDaily.